Promise Bio: Valuation, Funding & Investors
Promise Bio is a company focused on revolutionizing the treatment of immune-mediated diseases through advanced precision medicine solutions. It has developed a breakthrough platform that combines epiproteomics and artificial intelligence to identify predictive biomarkers, enabling personalized treatments and supporting drug development.
Leadership & Board
- Current Number of Employees
- 13
- Current LinkedIn Followers
- 1,600
Latest Estimated Valuation
- Total Amount Raised
- $8M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $8M
- Latest Funding Round
- Seed Round
Employee Trend
Promise Bio had 13 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
13Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Promise Bio had 1,600 followers as of November 16, 2026. The number of followers increased by 9 (0.57%) week-over-week.
1,600Latest Followers Count
9(0.57%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Seed Round | $8.30M | ― |
Similar Companies
A snapshot of private companies similar to Promise Bio, helping you discover and navigate related company profiles.
Related News and Analysis







